- July 17, 2019
- Rockwell Automation
- Rockwell Automation
The Switzerland-based company, founded in 1897 with approximately 15,500 employees, chose Rockwell Automation‚Äôs PharmaSuite Manufacturing Execution System (MES) software to digitize the operations in their manufacturing environments
July 17, 2019 — Lonza has selected Rockwell Automation for the turnkey implementation of the Lonza strategic vision of bringing the digital factory to nine former Capsugel facilities that manufacture drug capsules. The Switzerland-based company, founded in 1897 with approximately 15,500 employees, chose Rockwell Automation’s PharmaSuite Manufacturing Execution System (MES) software to digitize the operations in their manufacturing environments. Specifically, the solution is designed to help avoid disruptions during high volume periods of just-in-time orders for on-demand production. Rockwell Automation services all of the top 10 global life sciences firms, offering expertise in scalable digital transformation, industrial analytics, and IoT solutions for fully automated manufacturing environments. This deployment to nine sites will also provide 1,500 employees across the globe new, operational technology-centric tools for reaching the next level of efficiency and quality. Lonza will use PharmaSuite MES software, along with FactoryTalk InnovationSuite software to better trace product down to the individual capsule carton and gain insights into performance and production. A segregation of SAP and PharmaSuite MES will also help avoid the disruption in case of a global enterprise resource planning ERP shutdown or required maintenance by enforcing workflows and collecting necessary information. About Rockwell Automation
Rockwell Automation is dedicated to industrial automation and information, makes its customers more productive and the world more sustainable. Headquartered in Milwaukee, Wis., Rockwell Automation employs approximately 23,000 people serving customers in more than 80 countries.Learn More
Did you enjoy this great article?
Check out our free e-newsletters to read more great articles..Subscribe